bluebird bio Inc (BLUE)
0.348
+0.05
(+16.82%)
USD |
NASDAQ |
Nov 22, 16:00
0.34
-0.01
(-2.30%)
After-Hours: 20:00
bluebird bio Shareholders Equity (Quarterly): -5.786M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | -5.786M |
June 30, 2024 | 52.98M |
March 31, 2024 | 131.05M |
December 31, 2023 | 194.54M |
September 30, 2023 | 222.54M |
June 30, 2023 | 289.02M |
March 31, 2023 | 354.74M |
December 31, 2022 | 134.33M |
September 30, 2022 | 158.86M |
June 30, 2022 | 180.12M |
March 31, 2022 | 263.26M |
December 31, 2021 | 374.28M |
September 30, 2021 | 870.53M |
June 30, 2021 | 984.56M |
March 31, 2021 | 1.200B |
December 31, 2020 | 1.355B |
September 30, 2020 | 1.523B |
June 30, 2020 | 1.682B |
March 31, 2020 | 1.120B |
December 31, 2019 | 1.285B |
September 30, 2019 | 1.472B |
June 30, 2019 | 1.636B |
March 31, 2019 | 1.772B |
December 31, 2018 | 1.885B |
Date | Value |
---|---|
September 30, 2018 | 2.001B |
June 30, 2018 | 1.458B |
March 31, 2018 | 1.570B |
December 31, 2017 | 1.623B |
September 30, 2017 | 1.141B |
June 30, 2017 | 1.200B |
March 31, 2017 | 815.38M |
December 31, 2016 | 869.44M |
September 30, 2016 | 694.51M |
June 30, 2016 | 759.29M |
March 31, 2016 | 806.51M |
December 31, 2015 | 850.50M |
September 30, 2015 | 889.01M |
June 30, 2015 | 918.97M |
March 31, 2015 | 474.50M |
December 31, 2014 | 491.26M |
September 30, 2014 | 261.89M |
June 30, 2014 | 165.76M |
March 31, 2014 | 144.16M |
December 31, 2013 | 151.67M |
September 30, 2013 | 157.70M |
June 30, 2013 | 161.27M |
March 31, 2013 | 58.50M |
December 31, 2012 | -55.75M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-5.786M
Minimum
Sep 2024
1.682B
Maximum
Jun 2020
618.54M
Average
321.88M
Median
Shareholders Equity (Quarterly) Benchmarks
AIM ImmunoTech Inc | 2.912M |
Perspective Therapeutics Inc | 328.47M |
Protalix BioTherapeutics Inc | 32.44M |
Electromed Inc | 41.49M |
Armata Pharmaceuticals Inc | -50.97M |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 465.06M |
Total Liabilities (Quarterly) | 470.84M |
Debt to Equity Ratio | -12.20 |
Current Ratio | 0.5094 |
Net Debt Paydown Yield | -14.02% |